Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05077826 · ClinicalTrials.gov registry record · NA
Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease
A NA study, sponsored by The Mind Research Network.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT05077826 is a NA study that has completed, run by The Mind Research Network. The registered enrollment target is 98 participants.
The verdict
NCT05077826, a NA study, has completed, sponsored by The Mind Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
The investigators have developed a low-risk transcranial Electrical Stimulation (tES) treatment that has improved learning and performance in young adults up to nearly 4 times when compared with a sham control. This randomized pilot trial will determine if this same tES protocol improves memory in older adults (50-90 years old) who are healthy, and separately in older adults with mild cognitive impairment (MCI) or early stage Alzheimer's disease (AD). TES will be applied to the right temple and left arm for up to 40 minutes. MRI images, along with other measures, may be obtained before and after tES. If effective, this intervention may help to improve the quality of life for AD patients and their families.
Interventions
- DEVICE North Coast Medical Activadose II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05077826
The ClinicalTrials.gov registry entry for NCT05077826 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Mind Research Network, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which North Coast Medical Activadose II is the first listed.
NCT05077826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05077826 about?
NCT05077826 is a clinical study titled "Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease". The investigators have developed a low-risk transcranial Electrical Stimulation (tES) treatment that has improved learning and performance in young adults up to nearly 4 times when compared with a sham control. This randomized pilot trial will determine if this same tES protocol improves memory in o...
What is the current status of trial NCT05077826?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2021-10-07. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT05077826?
The interventions under investigation include: North Coast Medical Activadose II (DEVICE).
Who is sponsoring clinical trial NCT05077826?
This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.